Author Affiliation: Department of Anesthesiology, University of California, Davis (email@example.com).
To the Editor: I was requested to add 2 financial disclosures related to a letter to the editor1 published in JAMA. I previously disclosed that I authored the Federation of State Medical Board book Responsible Opioid Prescribing and received no royalties. Additionally, I am disclosing that I am president and chair of the board of directors of the American Pain Foundation (a nonprofit foundation that receives some of its support from manufacturers of prescription opioids) for which I received no compensation. However, one time per year I am reimbursed for out-of-pocket expenses for coach airfare and cab fare for an annual board meeting. I have participated in numerous ACCME-certified continuing medical education activities yearly for which I received market rate honoraria. These programs were organized by academic health systems and/or medical professional organizations and some were funded by commercial sources related to opioid prescribing. I have not accepted any funds directly from any commercial sponsors. These disclosures were not originally reported because I did not believe that travel reimbursement and/or CME honoraria from academic health systems or health professional organizations for speaking at ACCME-certified programs required disclosure. I regret any inconvenience this may have caused and appreciate the opportunity to provide an explanation. A correction and related letter appear in this issue of JAMA, and the original letter to the editor has been corrected online.
Fishman SM. Incomplete Financial Disclosures in a Letter on Reducing Opioid Abuse and Diversion. JAMA. 2011;306(13):1445. doi:10.1001/jama.2011.1398